Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |
Merck And Co., Inc patentsThe following is a sampling of recent Merck And Co., Inc patent applications (USPTO Patent Application #, Patent Title) sorted by month.
April 2010 - Merck And Co., Inc patents
20100099743 - Rna interference mediated inhibition of checkpoint kinase-1 (chk-1) gene expression using short interfering nucleic acid (sina)
20100099744 - Rna interference mediated inhibition of matrix metalloproteinase 13 (mmp13) gene expression using short interfering nucleic acid (sina)
20100099750 - Rna interference mediated inhibition of muscarinic colinergic receptor gene expression using short interfering nucleic acid (sina)
20100099673 - Decahydroquinoline analogs as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases
20100099695 - Hcv ns3 protease inhibitors
20100099716 - Cetp inhibitors
20100099923 - Process for the preparation of bicyclo[3.1.0]hexanols
20100092505 - Method for shielding functional sites or epitopes on proteins
20100093665 - Silylated piperidine derivatives
20100093759 - Bicyclic anilide heterocyclic cgrp receptor antagonists
20100093779 - Hcv ns3 protease inhibitors
20100093811 - Hiv protease inhibitors
20100087360 - Heterocycle-substituted benzimidazole derivative
20100087419 - Hiv integrase inhibitors
20100087446 - 2-substituted indole derivatives as calcium channel blockers
20100081643 - Novel cyclic benzimidazole derivatives useful as anti-diabetic agents
20100081642 - Cb-1 receptor modulator pharmaceutical formulations
20100081696 - Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
March 2010 - Merck And Co., Inc patents
20100074888 - Animal having modification in mgat2 gene
20100075907 - Neuromedin u receptor agonists and uses thereof
20100076059 - Method of evaluating compound efficacious in treating obesity by using slc25a10
20100075970 - Inhibitors of akt activity
20100075987 - Acyl bipiperidinyl compounds, compositions containing such compounds and methods of treatment
20100076002 - Method of treating atherosclerosis, dyslipidemias and related conditions and pharmaceutical compositions
20100076004 - Bicyclic spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
20100076046 - Antiviral indoles
20100069347 - Heterocyclyl-substituted anti-hypercholesterolemic compounds
20100069359 - Constrained spirocyclic compounds as cgrp receptor antagonists
20100069419 - Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
20100069452 - Mineralocorticoid receptor modulators
20100062516 - Expression of class 2 mannosidase and class iii mannosidase in lower eukaryotic cells
20100062523 - Expression of class 2 mannosidase and class iii mannosidase in lower eukaryotic cells
20100063013 - Cathepsin cysteine protease inhibitors
20100063024 - Dihydropyrazolopyrimidinone derivatives
20100063032 - Substituted pyrido[2,3-d]pyrimidine derivatives as cannabinoid-1 receptor modulators
20100063056 - Bipyridine carboxamide orexin receptor antagonists
20100063091 - Renin inhibitors
20100063308 - Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
20100056498 - Substituted monocyclic cgrp receptor antagonists
20100056516 - 1-hydroxy naphthyridine compounds as anti-hiv agents
20100056550 - Tricyclic heteroaromatic compounds as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
20100056563 - Novel 1.8-naphthyridine compounds
20100056580 - Novel crystalline salt form of an antidiabetic compound
20100056597 - Indoledione derivative
February 2010 - Merck And Co., Inc patents
20100048551 - Tricyclic compounds useful as inhibitors of kinases
20100048555 - Imidazothiazole derivatives as mark inhibitors
20100048600 - Novel benzimidazole derivatives
20100048623 - Piperidines and related compounds for the treatment of alzheimer's disease
20100048717 - Cathepsin b inhibitors
20100048888 - Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
20100040610 - Antagonists of pcsk9
20100040611 - Antagonists of pcsk9
20100041026 - Method for identiflying modulators of rufy2 useful for treating alzheimer's disease
20100041097 - Synthetic gene control region
20100041102 - Antagonists of pcsk9
20100041652 - Tyrosine kinase inhibitors
20100041660 - Novel 2-pyridinecarboxamide derivatives
20100041667 - Piperidine and pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
20100041680 - Piperidine derivatives
20100041724 - Process for synthesizing a cetp inhibitor
20100041893 - Formation of tetra-substituted enamides and stereoselective reduction thereof
20100035818 - Optimized expression of hpv 52 l1 in yeast
20100035835 - Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
20100035857 - Anti-hypercholesterolemic compounds
20100035931 - Tripyridyl carboxamide orexin receptor antagonists
20100035991 - Amide base salts of saha and polymorphis thereof
20100036135 - Process for making hydroisoindoline tachykinin receptor antagonists
20100028333 - Receptor for amyloid beta and uses thereof
20100028951 - Production of glycoproteins with modified fucosylation
20100029012 - Method for identifying modulators of the nrf2-keap1-arep pathway
20100029666 - Macrocyclic quinoxaline compounds as hcv ns3 protease inhibitors
20100029678 - Diuretics
20100029688 - Bipiperidinyl compounds, compositions containing such compounds and methods of treatment
20100029697 - Substituted pyrido[3,2-e][1,2,4]triazolo[4,3-c]pyrimidine derivatives as cannabinoid-1 receptor modulators
20100029701 - Macrocyclic spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
20100029726 - Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia
20100029736 - 2-substituted proline bis-amide orexin receptor antagonists
January 2010 - Merck And Co., Inc patents
20100021991 - Methods for producing modified glycoproteins
20100022404 - Gene/protein marker for prediction or diagnosis of pharmacological efficacy of aurora a inhibitor
20100022468 - Nucleoside cyclic phosphoramidates for the treatment of rna-dependent rna viral infection
20100022477 - Fused aromatic ptp-1b inhibitors
20100022573 - Inhibitors of akt activity
20100022598 - Substituted inmidazoles as bombesin receptor subtype-3 modulators
20100022630 - Method of treatment using fatty acid synthesis inhibitors
20100022771 - Reaction apparatus, and reaction method
20100015218 - Compositions and methods for potentiated activity of biologically active molecules
20100016308 - Tetrahydroindole derivatives for treatment of alzheimer's disease
20100016335 - Novel aminopyridine derivatives having aurora a selective inhibitory action
20100016555 - N-acetylglucosaminyltransferase iii expression in lower eukaryotes
20100016561 - N-acetylglucosaminyltransferase iii expression in lower eukaryotes
20100017894 - Mutants of human app and their use for the production of transgenice animals
20100009461 - Npcil1 (npc3) and methods of identifying ligands thereof
20100009866 - Surface display of whole antibodies in eukaryotes
20100009957 - Novel inhibitors of beta-lactamase
20100009959 - Pentacyclic indole derivatives as antiviral agents
20100009962 - Benzyl-substituted quinolone m1 receptor positive allosteric modulators
20100009967 - Solid dosage formulations of telcagepant potassium
20100009987 - Aminothiazole derivatives as inhibitors of mark
20100010041 - Difluorinated piperidines for treatment of alzheimer's disease and related conditions
20100003276 - Methods for treating anthrax and inhibiting lethal factor
20100003665 - Real-time hpv pcr assays
20100004158 - Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
20100004184 - Anti-hypercholesterolemic compounds
20100004229 - Potassium channel inhibitors
20100004245 - Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
20100004280 - Substituted imidazoles as bombesin receptor subtype-3 modulators
20100004287 - Cyclic derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
December 2009 - Merck And Co., Inc patents
20090325862 - Histone deacetylase inhibitors for the treatment of neurodegeneration
20090325936 - Imidazopyridine analogs as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases
20090325953 - P38 kinase inhibiting agents
20090325990 - Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
20090325991 - Spirolactam bicyclic cgrp receptor antagonists
20090317840 - Automated determination of chlamydia infection-forming units
20090317850 - Crystal structure of human 70kd ribosomal protein s6 kinase 1 kinase domain
20090318476 - Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
20090318518 - Indole and indoline cyclopropyl amide derivatives as ep4 receptor antagonists
20090318541 - Benzothiophene hydroxamic acid derivatives with carbamate, urea, amide and sulfonamide substitutions
20090318560 - Formulations for cathepsin k inhibitors
20090312241 - Macrocyclic compounds as antiviral agents
20090312303 - Antidiabetic bicyclic compounds
20090312335 - Hiv integrase inhibitors
20090304594 - Methods for predicting treatment response based on the expression profiles of protein and transcription biomarkers
20090305314 - Upregulation of adamts4 protease activity for the treatment of alzheimer's disease
20090306037 - Combination of a dipeptidyl peptidase-iv inhibitor and a cannabinoid cb1 receptor antagonist for the treatment of diabetes and obesity
20090306058 - Sulphone derivatives for treatment of cancer
20090306071 - Inhibitors of janus kinases
20090306076 - Morpholine carboxamide prokineticin receptor antagonists
20090306115 - Phenyl ethyne compounds
20090306169 - Use of fused pyrrole carboxylic acids for the treatment of neurodegenerative and psychiatric diseases and d-amino acid oxidase inhibitors
20090306202 - D-homoandrosta-17-yl carbamate derivatives as selective glucocorticoid receptor ligands
20090306375 - Process for production of 4(3h)-quinazolinone derivative
20090298046 - Assays for histone deacetylase 1/2 selective inhibitors
20090298073 - Kidney toxicity biomarkers
20090298856 - 2,3 substituted fused bicyclic pyrimidin-4(3h)-ones modulating the function of the vanilliod-1receptor (vr1)
20090298949 - Aminoalkylphenols, methods of using and making the same
November 2009 - Merck And Co., Inc patents
20090291941 - Tyrosine kinase inhibitors
20090291955 - Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
20090291965 - Histone deacetylase inhibitors with aryl-pyrazolyl-motifs
20090291988 - Reversible inhibitors of monoamine oxidase a and b
20090282913 - Method and apparatus for measuring the volume of an animal paw
20090286765 - Therapeutic agents
20090286772 - 2-(phenyl or heterocyclic)-1h-phenanthro[9,10-d]imidazoles
20090286777 - 5,6,fused pyrrolidine compounds useful as tachykinin receptor antagonists
20090286825 - Indole derivatives as crth2 receptor antagonists
20090281080 - Spirohydantoin tricyclic cgrp receptor antagonists
20090281080 - Spirohydantoin tricyclic cgrp receptor antagonists
20090281103 - Renin inhibitors
20090281103 - Renin inhibitors
20090281117 - Substituted imidazole-4-carboxamides as cholecystokinin -1 receptor modulators
20090281117 - Substituted imidazole-4-carboxamides as cholecystokinin -1 receptor modulators
20090281154 - Ophthalmic compositions for treating ocular hypertension
20090281154 - Ophthalmic compositions for treating ocular hypertension
20090281306 - Process for the preparation of cgrp antagonist
20090281306 - Process for the preparation of cgrp antagonist
20090275515 - 2-hydroxy-2-phenylthiophenylpropionamides as androgen receptor modulators
20090275515 - 2-hydroxy-2-phenylthiophenylpropionamides as androgen receptor modulators
20090275550 - Pyridyl amide t-type calcium channel antagonists
20090275550 - Pyridyl amide t-type calcium channel antagonists
20090275617 - Aryl-substituted nitrogen-containing heterocyclic compounds
20090275617 - Aryl-substituted nitrogen-containing heterocyclic compounds
20090275619 - Amide substituted indazole and benzotriazole derivatives as poly(adp-ribose)polymerase (parp) inhibitors
20090275619 - Amide substituted indazole and benzotriazole derivatives as poly(adp-ribose)polymerase (parp) inhibitors
July 2009 - Merck And Co., Inc patents
20090191552 - Novel human acidic mammalian chitinase and use thereof
20090191578 - Canis sphingosine 1-phosphate receptor isoform 5
20090192139 - Cgrp receptor antagonists
20090192143 - Substituted diazepan orexin receptor antagonists
20090192155 - Identification of compounds suitable for treating ad
20090192158 - Methods for treating or preventing neoplasias
20090192174 - Novel aminopyridine derivatives having aurora a selective inhibitory action
20090186871 - Tyrosine kinase inhibitors
20090186919 - Piperidine derivatives for treatment of alzheimer's disease
20090186926 - Self-emulsifying formulations of cetp inhibitors
20090186928 - Novel crystalline forms of an inhibitor of 11-beta-hydroxysteroid dehydrogenase type 1
20090187028 - Process for preparing chiral dipeptidyl peptidase -iv inhibitor intermediates
20090181946 - Benzaepinones as sodium channel blockers
20090181994 - Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
20090182001 - Inhibitors of checkpoint kinases
20090182002 - Tyrosine kinase inhibitors
20090182021 - Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease
20090176243 - Novel monkey gpr103 and monkey qrfp and method of evaluating compound by using gpr103
20090176263 - Canis sphingosine 1-phosphate receptort isoform 1
20090176757 - Bicyclic spirohydantoin cgrp receptor antagonists
20090176765 - Pyridinone and pyridazinone derivatives as inhibitors of poly (adp-ribose) polymerase (parp)
20090176789 - Diazaspirodecane orexin receptor antagonists
20090176836 - Cyclic ketal beta-secretase inhibitors for the treatment of alzheimer's disease
20090176854 - Pyrazole derivatives, compositions containing such compounds and methods of use
20090176859 - Cathepsin cysteine protease inhibitors
20090176861 - Cathepsin cysteine protease inhibitors
20090176986 - Process for the preparation of pyridine heterocycle cgrp antagonist intermediate
20090170159 - Production of glycoproteins with reduced o-glycosylation
20090170824 - Diarylsulfones as 5-ht2a antagonists
20090170828 - Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
20090170830 - Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease
20090170863 - Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
20090170891 - Niacin receptor agonists, compositions containing such compounds and methods of treatment
June 2009 - Merck And Co., Inc patents
20090162377 - Immunoglobulins comprising predominantly a gal2glcnac2man3glcnac2 glycoform
20090162377 - Immunoglobulins comprising predominantly a gal2glcnac2man3glcnac2 glycoform
20090163379 - Eukaryotic cell display systems
20090163379 - Eukaryotic cell display systems
20090163544 - Use of nk-3 receptor antagonists for the treatment of nausea and vomiting
20090163544 - Use of nk-3 receptor antagonists for the treatment of nausea and vomiting
20090163559 - Estrogen receptor modulators
20090163559 - Estrogen receptor modulators
20090155298 - Matrix metalloproteinase 11 vaccine
20090155847 - Combinatorial dna library for producing modified n-glycans in lower eukaryotes
20090156579 - Combination of a dipeptidyl peptidase-4 inhibitor and an anti-hypertensive agent for the treatment of diabetes and hypertension
20090156591 - Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors
20090156617 - Tyrosine kinase inhibitors
20090156619 - Heterocycle substituted amide and sulfur amide derivatives as histone deacetylase (hdac) inhibitors
20090156825 - Fluorescent compounds that bind to histone deacetylase
20090148850 - Methods for identifying modulators of p2ry14
20090149398 - 6,11-3c-bicyclic 8a-azalide derivatives
20090149467 - Tyrosine kinase inhibitors
20090149470 - Novel aminopyridine derivatives having aurora a selective inhibitory action
20090149526 - Tetracyclic indole derivatives as antiviral agents
20090143413 - Thiazole derivatives as cxcr3 receptor modulators
20090143429 - Quinoline derivatives as neurokinin receptor antagonists
May 2009 - Merck And Co., Inc patents
20090136449 - Tetracyclic indole derivatives as antiviral agents
20090136525 - Immunoglobulins comprising predominantly a glcnacman3glcnac2 glycoform
20090136570 - Taste-masked tablets and granules
20090136979 - Class iia histone deacetylase (hdac) substrate
20090137529 - Substituted esters as cannabinoid-1 receptor modulators
20090137546 - Anti-hypercholesterolemic compounds
20090137548 - 1,3-oxazolidin-2-one derivatives useful as cetp inhibitors
20090137576 - Novel piperidine derivative
20090137587 - Phenylpyridone derivative
20090130709 - Endomannosidases in the modification of glycoproteins in eukaryotes
20090131419 - Sulphones which modulate the action of gamma secretase
20090131423 - Tyrosine kinase inhibitors
20090131451 - Diagnosis and treatment of type 2 diabetes and other disorders
20090131464 - Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors
20090131465 - Synthesis and crystalline forms of melanocortin-4 receptor agonist
20090131472 - P38 kinase inhibiting agents
20090131494 - Non-nucleoside reverse transcriptase inhibitors
20090131664 - Method for producing 4(3h)-quinazolinone derivative
20090123538 - Angiotensin ii receptor antagonists
20090123571 - Method of treating men with testosterone supplement and 5alpha-reductase inhibitor
20090124000 - Recombinant vectors
20090124600 - N-alkyl-azacycloalkyl nmda/nr2b antagonists
20090124601 - Tartaric acid salts of a dipeptidyl peptidase-iv inhibitor
20090124603 - Diazepan orexin receptor antagonists
20090124641 - Mitotic kinesin inhibitors
20090124648 - Synthesis and crystalline forms of npy5 antagonist
20090124661 - Hcv ns3 protease inhibitors
20090124665 - Potassium channel inhibitors
20090124689 - Cetp inhibitors
20090124799 - Process for the preparation of caprolactam cgrp antagonist
20090117590 - Human calcium sensitive potassium channel beta3 subunit proteins, encoding nucleic acid and uses thereof
20090117616 - Methods for reducing or eliminating alpha-mannosidase resistant glycans for the production of glycoproteins
20090118200 - Proline bis-amide orexin receptor antagonists
20090118223 - Novel 2'-c-methyl and 4'c-methyl nucleoside derivatives
20090118291 - Histone deacetylase inhibitors
20090118296 - Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
20090118300 - Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators
20090118304 - 2-heteroaryl-substituted indole derivative
April 2009 - Merck And Co., Inc patents
20090111832 - Imidazolidinone compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
20090111997 - Method of generating amorphous solid for water-insoluble pharmaceuticals
20090104210 - Peptide compounds for treating obesity and insulin resistance
20090104210 - Peptide compounds for treating obesity and insulin resistance
20090104210 - Peptide compounds for treating obesity and insulin resistance
20090104220 - Method to make a peptide-carrier conjugate with a high immunogenicity
20090104220 - Method to make a peptide-carrier conjugate with a high immunogenicity
20090104220 - Method to make a peptide-carrier conjugate with a high immunogenicity
20090105136 - Npy y2 agonist for use as therapeutic agent for disease accompanied by diarrhea
20090105136 - Npy y2 agonist for use as therapeutic agent for disease accompanied by diarrhea
20090105136 - Npy y2 agonist for use as therapeutic agent for disease accompanied by diarrhea
20090105210 - Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
20090105210 - Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
20090105210 - Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
20090105219 - Spirolactam tricyclic cgrp receptor antagonists
20090105219 - Spirolactam tricyclic cgrp receptor antagonists
20090105219 - Spirolactam tricyclic cgrp receptor antagonists
20090105227 - Thienopyrroles as antiviral agents
20090105227 - Thienopyrroles as antiviral agents
20090105227 - Thienopyrroles as antiviral agents
20090105228 - Heterocyclic benzodiazepine cgrp receptor antagonists
20090105228 - Heterocyclic benzodiazepine cgrp receptor antagonists
20090105228 - Heterocyclic benzodiazepine cgrp receptor antagonists
20090105234 - Ep4 receptor agonist, compositions and methods thereof
20090105234 - Ep4 receptor agonist, compositions and methods thereof
20090105234 - Ep4 receptor agonist, compositions and methods thereof
20090105264 - Substituted nicotinamide compounds
20090105265 - Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin
20090105264 - Substituted nicotinamide compounds
20090105265 - Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin
20090105264 - Substituted nicotinamide compounds
20090105265 - Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin
20090105270 - Kinase inhibition and anticancer therapy
20090105270 - Kinase inhibition and anticancer therapy
20090105270 - Kinase inhibition and anticancer therapy
20090105284 - Aminocyclohexanes as dipeptidyl peptidase-iv for the treatment or prevention of diabetes
20090105284 - Aminocyclohexanes as dipeptidyl peptidase-iv for the treatment or prevention of diabetes
20090105284 - Aminocyclohexanes as dipeptidyl peptidase-iv for the treatment or prevention of diabetes
20090105310 - Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
20090105310 - Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
20090105310 - Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
20090105318 - Amidoethylthioether orexin receptor antagonists
20090105318 - Amidoethylthioether orexin receptor antagonists
20090105318 - Amidoethylthioether orexin receptor antagonists
20090105321 - Indole amide derivatives as ep4 receptot ligands
20090105321 - Indole amide derivatives as ep4 receptot ligands
20090105321 - Indole amide derivatives as ep4 receptot ligands
20090105479 - 4-oxo-1-3-substituted phenyl-1,4-dihydro-1,8-napthyridene-3-carboxamide phosphodiesterase-4 inhibitor and a method of preparing same
20090105479 - 4-oxo-1-3-substituted phenyl-1,4-dihydro-1,8-napthyridene-3-carboxamide phosphodiesterase-4 inhibitor and a method of preparing same
20090105479 - 4-oxo-1-3-substituted phenyl-1,4-dihydro-1,8-napthyridene-3-carboxamide phosphodiesterase-4 inhibitor and a method of preparing same
20090098155 - Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease
20090098604 - Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof
20090099126 - Ribonucleoside cyclic acetal derivatives for the treatment of rna-dependent rna viral infection
20090099168 - Hiv integrase inhibitors
20090099200 - Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
20090099226 - Quinoline derivatives as ep4 antagonists
20090099264 - Fluoroalkylamine derivatives as cathepsin inhibtors
20090092971 - Method for detecting p53 dysfunction, method for molecular diagnosis of cancer and method for evaluating compound effective in treating cancer
20090093020 - Methods for reducing or eliminating alpha-mannosidase resistant glycans in the production of glycoproteins
20090093444 - Cathepsin cysteine protease inhibitors
20090093527 - Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
20090093552 - Addition of lecithin as an antistatic agent for the crystallization processing of organic molecules
20090088431 - Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
20090088431 - Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
20090088436 - P38 kinase inhibiting agents
20090088436 - P38 kinase inhibiting agents
20090088452 - Indole orexin receptor antagonists
20090088452 - Indole orexin receptor antagonists
20090088458 - N-(pyridin-4-yl)-2-phenylbutanamides as androgen receptor modulators
20090088458 - N-(pyridin-4-yl)-2-phenylbutanamides as androgen receptor modulators
20090088477 - Compounds and methods for leukotriene biosynthesis inhibition
20090088477 - Compounds and methods for leukotriene biosynthesis inhibition
20090089889 - Neuromedin u receptor subtype 1 deficient transgenic mice and uses thereof
20090089889 - Neuromedin u receptor subtype 1 deficient transgenic mice and uses thereof
March 2009 - Merck And Co., Inc patents
20090081645 - Method of assuming drug sensitivity to cdk4 inhibitor
20090081681 - Method for genetic selection of high-plasmid producing e. coli clones
20090082221 - Cross-species and multi-species display systems
20090082308 - Benzothiophene derivatives
20090082320 - Fluorinated 4-azasteroid derivatives as androgen receptor modulators
20090074890 - Substituted triazoles as sodium channel blockers
20090075319 - Method of detecting reactive metabolite
20090075869 - Hcv ns3 protease inhibitors
20090075979 - Cetp inhibitors
20090075998 - 2-(phenyl or heterocyclic)-1h-phenantrho[9,10-d]imidazoles as mpges-1 inhibitors
20090076101 - Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors
20090068678 - Method for identifying modulators of noah10 useful for treating alzheimer's disease
20090069250 - Inhibitors of histone deacetylase
20090069283 - Potassium channel inhibitors
20090069284 - Substituted 3-alkyl and 3-alkenyl azetidine derivatives
20090069312 - Potassium channel inhibitors
20090069344 - Modulators of hcv replication
20090069376 - Vla-4 antagonists
20090069385 - Antidiabetic oxazolidinediones and thiazolidinediones
20090069391 - Benzothiophene hydroxamic acid derivatives
20090062269 - Niacin receptor agonists, compositions containing such compounds and methods of treatment
20090062280 - Ophthalmic compositions for treating ocular hypertension
20090062293 - 1,4-substituted piperazine derivatives
20090062297 - Hydroxyalkylarylamide derivatives
20090062302 - Jak2 tyrosine kinase inhibition
20090062327 - Inhibitors of akt activity
20090062349 - 1-hydroxycycloalkanecarboxamide derivatives
February 2009 - Merck And Co., Inc patents
20090054399 - Hiv integrase inhibitors
20090054408 - Monocyclic anilide spirolactam cgrp receptor antagonists
20090054423 - Niacin receptor agonists, compositions containing such compounds and methods of treatment
20090054440 - Quinoline derivatives as neurokinin receptor antagonists
20090054448 - Amino acid derivatives as histone deacetylase (hdac) inhibitors
20090054462 - Hydroisoindoline tachykinin receptor antagonists
20090054483 - Substituted quinolines as inhibitors of leukotriene biosynthesis
20090054506 - Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
20090054662 - Process for synthesizing a substituted pyrazole
20090047303 - Method for improving the immunogenicity of plasmodium antigens
20090047702 - Method for identifying modulators of keah6 useful for treating alzheimer's disease
20090048227 - Substituted-1-phthalazinamines as vr- 1 antagonists
20090048228 - Heterocycle derivatives as histone deacetylase (hdac) inhibitors
20090048239 - Therapeutic compounds
20090048248 - Octahydropyrano[3,4-c]pyrrole tachykinin receptor antagonists
20090048276 - Inhibitors of fatty acid synthase (fas)
20090048283 - Salt of an androgen receptor modulator
20090048308 - Vla-4 antagonists
20090042854 - Hexahydro-3h-pyrrolizin-3-ones useful as tachykinin receptor antagonists
20090042892 - Cetp inhibitors
20090042926 - Niacin receptor agonists, compositions containing such compounds and methods of treatment
20090042944 - Potassium channel inhibitors
20090042954 - 2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as s1p receptor antagonists
20090042966 - Mitotic kinesin inhibitors
20090035277 - Hepatitis c virus nucleic acid vaccine
20090036443 - Thienopyrroles as antiviral agents
20090036503 - Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
January 2009 - Merck And Co., Inc patents
20090029406 - Npy y4 agonist as therapeutic agent for disease accompanied by intestinal tract dysfunction
20090030012 - Pyridine, pyrimidine and pyrazine derivatives as cxcr3 receptor modulators
20090030043 - Potassium channel inhibitors
20090030048 - Novel pharmaceutical compounds
20090023163 - Method of measuring enzyme activity and method of evaluating compound
20090023767 - Inhibitors of checkpoint kinases
20090023774 - Pyridine analogs as c5a antagonists
20090025095 - Method for evaluating compound using barlp and substance for regulating eating and body weight
20090017468 - Method of screening compound directly activating glycogen synthase
20090018054 - Cholesteryl ester transfer protein inhibitors
20090018056 - Heteroarylcarbamoylbenzene derivatives
20090018340 - Formation of tetra-substituted enamides and stereoselective reduction thereof
20090012061 - A method of treating cancer
20090012075 - Fluorinated arylamide derivatives
20090012076 - Tyrosine kinase inhibitors
20090012134 - Arylsulfonyl benzofused heterocycles as 5-ht2a antagonists
20090005323 - Cathepsin k inhibitors and obesity
20090005389 - 2,5 diaza-bicyclo [2.2.1] heptane derivatives as calcium channel blockers
20090005418 - Mitotic kinesin inhibitors
20090007283 - Transgenic rodents selectively expressing human b1 bradykinin receptor protein
October 2008 - Merck And Co., Inc patents
20080261938 - Tetracyclic indole derivatives as antiviral agents
20080261944 - Indole derivatives as antiviral agents
20080261972 - Cgrp receptor antagonists
20080262035 - Amide derivatives as inhibitors of histone deacetylase
20080262046 - Amidopropoxyphenyl orexin receptor antagonists
20080262051 - Triazole derivatives which are smo antagonists
20080254059 - Adenovirus serotype 26 vectors, nucleic acid and viruses produced thereby
20080255072 - Composition for inhibition of cathepsin k
20080255216 - Diaryltriazoles as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
20080248040 - Nucleic acid molecules encoding novel human low-voltage activated calcium channel proteins, designed-alpha 1i-1 and alpha 1i-2, encoded proteins and methods of use thereof
20080248062 - Papillomavirus vaccine compositions
20080249093 - (3,4-disubstituted)propanoic carboxylates as sip (edg) receptor agonists
20080249146 - Imidazole and thioazole derivatives as antiviral agents
20080242597 - Antibiotic compounds
20080242643 - Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
20080242657 - Treatment of tremor with histamine h3 inverse agonists or hist amine h3 antagonists
20080242722 - Combination therapy for treating cyclooxygenase-2 mediated diseases or conditions in patients at risk of thrombotic cardiovascular events
September 2008 - Merck And Co., Inc patents
20080234281 - Mitotic kinesin inhibitors
20080226660 - Optimized expression of hpv 58 l1 in yeast
20080227758 - Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
20080227778 - Isoquinolinone potassium channel inhibitors
20080227786 - Novel crystalline salts of a dipeptidyl peptidase-iv inhibitor
20080221157 - Amide derivatives as inhibitors of histone deacetylase
20080221198 - Novel crystalline forms of antidiabetic compounds
20080214511 - Tricyclic anilide spirolactam cgrp receptor antagonists
20080214522 - Antiviral indoles
20080214594 - Inhibitors of checkpoint kinases
###
This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Merck And Co., Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Merck And Co., Inc with additional patents listed. Browse our Agent directory for other possible listings.
###
FreshPatents.com Support - Terms & Conditions
|
REGISTER now for FREE 
